Notable Upgrades: Netflix (NFLX), Facebook (FB), DexCom (DXCM), Nike (NKE), Apple (AAPL)

Netflix, Inc. (NFLX) was reiterated an ‘Outperform’ by Oppenheimer analysts on Thursday. The broker also raised its price target on the stock to $130 from $125, implying 29% expected upside.

NFLX is currently printing a higher than average trading volume with the issue trading 32.34 million shares, compared to the average volume of 22.78 million. The stock began trading this morning at $103.68 to currently trade 8.28% lower from the prior days close of $110.23. On an intraday basis it has gotten as low as $99.10 and as high as $104.88.

Netflix Inc. shares are priced at 226.73x this year’s forecasted earnings, compared to the industry’s 11.10x earnings multiple. The company’s next year EPS growth estimates stand at 45.50%, compared to the industry growth rates of 22.40%. NFLX has a t-12 price-to-sales ratio of 7.68. EPS for the same period registers at $0.45.

Netflix shares have advanced 11.16% in the last 4 weeks while declining 4.82% in the past three months. Over the past 5 trading sessions the stock has gained 1.97%. The Los Gatos, Calif.-based company, which is currently valued at $43.08 billion, has a median Wall Street price target of $125 with a high target of $175.

Netflix Inc. is up 71.80% year-over-year, compared with a 7.06% gain in the S&P 500.

Analysts at Argus are out with a report this morning upgrading shares of Facebook, Inc. (FB) with a ‘Buy’ from ‘Hold’ rating, noting expects the company to remain the dominant social media site.

Facebook Inc. Cl A shares are currently priced at 97.55x this year’s forecasted earnings, which makes them quite expensive compared to the industry’s 10.30x earnings multiple. Ticker has a forward P/E of 34.87, and t-12 price-to-sales ratio of 18.10. EPS for the same period is $0.98.

Over the past year, shares of Menlo Park, California-based company have traded between a low of $70.58 and a high of $99.24 and are now at $95.99.

Shares are up 20.57% since the beginning of year.

DexCom, Inc. (DXCM) was raised to ‘Outperform’ from ‘Market Perform’ at Leerink Partners on Thursday.

DXCM is up $11.80 at $82.45 on heavy volume. Midway through trading Thursday, 2.54 million shares of DexCom Inc. have exchanged hands as compared to its 3-month average daily volume of 1.13 million shares. The stock has ranged in a price between $76.49 to $83.32 after having opened the day at $80.14, vs. close of $70.65.

In the past 52 weeks, shares of San Diego, California-based company have traded between a low of $40.39 and a high of $103.29.

Shares are up 72.36% year-over-year and 28.34% year-to-date.

Nike, Inc. (NKE) was reiterated as ‘Buy’ with a $140 from $137 price target on Thursday by UBS. The name was also raised at Telsey Advisory Group to $137 from $136.

Nike shares recently gained $3.13 to $128.97. In the past 52 weeks, shares of Beaverton, Oregon-based company have traded between a low of $83.85 and a high of $129.17.

Shares are up 31.95% year-to-date.

Investment analysts at Barclays initiated coverage on shares of Apple Inc. (AAPL) with an ‘Overweight’ rating in a note issued to investors on Thursday. Separately, FBR & Co., which has an ‘Outperform’ and $175 target on the iPhone maker’s shares, expects Q415 revenue, EPS in-line with consensus estimates of $50.9 billion, $1.89, respectively, with 49 million iPhone units for the quarter.

Apple Inc., currently valued at $635.22 billion, has a median Wall Street price target of $150 with a high target of $200. Approximately 22 million shares have changed hands intraday, compared to the stock’s average daily volume of 54.07 million.

In the past 52 weeks, shares of the tech giant have traded between a low of $92 and a high of $134.54, with the 50-day MA and 200-day MA located at $112.16 and $121.77 levels, respectively. Additionally, shares of AAPL trade at a P/E ratio of 12.88 and have a Relative Strength Index (RSI) and MACD indicator of 46.83 and +0.23, respectively.

Apple Inc. currently prints a year-to-date return of around 1.10%.

Be the first to comment

Leave a Reply

Your email address will not be published.


*